MedTrace Logo

Predicting Concussion Outcomes With Salivary miRNA

NCT02901821 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2025-10-16

No results posted yet for this study

Summary

The purpose of this study is to identify changes in salivary ribosomal nucleic acid (RNA) expression that are predictive of symptom duration and character following mild traumatic brain injury (mTBI) in children.

Conditions

  • Concussion, Mild

Interventions

GENETIC

salivary RNA collection

collection of saliva for microRNA (small noncoding RNA) processing

Sponsors & Collaborators

  • Milton S. Hershey Medical Center

    lead OTHER

Principal Investigators

  • Steven Hicks, MD, PhD · Milton S. Hershey Medical Center

Eligibility

Min Age
5 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02901821 on ClinicalTrials.gov